House of Lords seeks clarity over post-Brexit medicines planning

A sub-committee in the UK House of Lords has written to the Health Secretary requesting information on what plans are in place to ensure continued access to medicines in the event of a so-called “no deal” Brexit.

While the UK and European Union have recently agreed on terms for a transitional period after the UK leaves the trading bloc in March 2019, the deal must be ratified by the UK Parliament.

Amid widespread dissatisfaction with the deal, it is not clear whether Prime Minister Theresa May has the required votes to push the agreement through.